Hotline 24/7: 0909384389

Share links:

VDYNE secures funding for studies of tricuspid valve replacement device

Ngày 07/01/1988 01:26 | Lượt xem: 788

VDYNE has announced today that it has secured a US$21 million Series C financing, proceeds of which will fund first-in-human studies of its tricuspid valve replacement device and delivery system. The financing round was supported by existing investors, including Jean Boulle Medtech, together with significant participation from a large, global medical device company.

VDYNE’s technology addresses tricuspid valve regurgitation, a condition whereby the heart can become enlarged due to impaired functionality of the tricuspid valve. The company’s novel valve replacement and minimally invasive delivery system enables the treatment of a broad range of tricuspid anatomies. VDYNE’s unique system delivers a prosthetic valve via a transfemoral catheter, and is completely repositionable and retrievable, the company said in a press release.

VDYNE is nearing completion of requisite pre-clinical studies and the proceeds from the financing will support the company’s first-in-human feasibility studies which are expected to commence in the first half 2021.

“The financing is a significant milestone for VDYNE and we warmly welcome a large, global medical device company to our investor base.  We are moving very quickly in our pre-clinical efforts and are looking forward to the commencement of human feasibility studies in the new year” commented Jean Raymond Boulle II, director of both VDYNE and Jean Boulle MedTech.

Source CardiovascularNews

Duc Tin Clinic

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support